LUNG vs BWAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

LUNG

32.1
AI Score
VS
BWAY Wins

BWAY

44.6
AI Score

Investment Advisor Scores

LUNG

32score
Recommendation
SELL

BWAY

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LUNG BWAY Winner
Forward P/E 28.3286 36.4964 LUNG
PEG Ratio 0 0 Tie
Revenue Growth -4.6% 34.6% BWAY
Earnings Growth 0.0% 200.0% BWAY
Tradestie Score 32.1/100 44.6/100 BWAY
Profit Margin -55.0% 15.6% BWAY
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD BWAY

Relative Price Performance (Last 90 Days)

LUNG 1M: +85.2% · 3M: +46.8% BWAY 1M: -10.7% · 3M: -2.3%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.1% over 20 days), RSI 64

RSI (14): 63.6 · Price: $2.26

BWAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.5 · Price: $14.74

Fundamentals Snapshot

Metric LUNG BWAY
Market Cap
Forward P/E -2.4 30.3
Trailing P/E 65.1
Revenue (TTM)
Revenue Growth 0.0% 0.4%
Gross Margin 0.8% 0.8%
Operating Margin -0.4% 0.1%
EPS -1.15 0.23
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BWAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.